Skip to main content
. 2020 Nov 19;6(2):e10197. doi: 10.1002/btm2.10197

FIGURE 5.

FIGURE 5

Administration of MMNPmiR199a‐3p inhibits expression of cardiac fibrosis markers. Relative mRNA expression levels of cardiac myofibroblast‐related genes, including TGFβ (a), ACTA2 (b), MMP2 (c), MMP9 (d), TIMP1 (e), and TIMP2 (f) in the peri‐infarct zone two week after treatment, as evaluated by real‐time PCR. Data represent means ± SD. n = 8. **p < .01, ***p < .001